These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 5354875)

  • 21. Calcitonin secretion in hyperthyroidism.
    Gozariu L; Duncea I; Florescu O; Popescu E; Dumitru E; Dascălu R
    Endocrinologie; 1982; 20(1):43-8. PubMed ID: 7071508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum calcitonin in hyperthyroidism.
    Földes J; Petrányi G; Takó J; Bános C; Krasznai I; Horváth C; Steczek K
    Acta Med Hung; 1983; 40(2-3):99-105. PubMed ID: 6689443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in parameters of bone and mineral metabolism during therapy for hyperthyroidism.
    Pantazi H; Papapetrou PD
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1099-106. PubMed ID: 10720046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteopathy in hyperthyroidism--a study of 47 calcium kinetics and quantitative histology of bone.
    Montz R; Hehrmann R; Langbein H; Schneider C; Haug HP; Delling G
    Acta Endocrinol Suppl (Copenh); 1973; 173():146. PubMed ID: 4542078
    [No Abstract]   [Full Text] [Related]  

  • 25. Calcium and skeletal metabolism.
    Deftos LJ; Roos BA; Parthemore JG
    West J Med; 1975 Dec; 123(6):447-58. PubMed ID: 1105981
    [No Abstract]   [Full Text] [Related]  

  • 26. [Hypercalcemia and hyperphosphatemia in thyrotoxoicosis and the therapeutic effect of propranolol].
    Wang XB; Chao CS; Wu HW
    Zhonghua Nei Ke Za Zhi; 1989 Nov; 28(11):646-8, 699. PubMed ID: 2632174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial benign hypercalcaemia. Study of a large family.
    Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
    Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immobilisation hypercalcaemia. 1 case (author's transl)].
    Baglin A; Goupil A; Lortat-Jacob A; Arfi S; Gueris J; Milhaud G; Benoit J
    Nouv Presse Med; 1978 Feb; 7(6):453-5. PubMed ID: 634783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.
    Lakatos P; Foldes J; Horvath C; Kiss L; Tatrai A; Takacs I; Tarjan G; Stern PH
    J Clin Endocrinol Metab; 1997 Jan; 82(1):78-81. PubMed ID: 8989237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Calcitonin and hypercalcaemia (author's transl)].
    Milhaud G; Calmettes C; Jullienne A; Moukhtar MS
    Sem Hop; 1978 Oct 8-15; 54(29-32):911-7. PubMed ID: 216080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of thyrotoxicosis and its treatment on mineral and bone metabolism.
    Lalau JD; Sebert JL; Marie A; Fournier A; Quichaud J
    J Endocrinol Invest; 1986 Dec; 9(6):491-6. PubMed ID: 3571853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Osteocalcin and hyperthyroidism].
    Pandolfi C; Montanari G; Mercantini F; Sbalzarini G
    Minerva Endocrinol; 1992; 17(2):75-8. PubMed ID: 1296147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P; Foldes J; Nagy Z; Takacs I; Speer G; Horvath C; Mohan S; Baylink DJ; Stern PH
    Thyroid; 2000 May; 10(5):417-23. PubMed ID: 10884189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Calcium tolerance in patients with thyroid diseases with reference to calcitonin secretion].
    Eydenreich G; Bock JE
    Nord Med; 1970 Feb; 83(8):238-42. PubMed ID: 5444946
    [No Abstract]   [Full Text] [Related]  

  • 35. Interactions of thyroxine and thyrocalcitonin in the rat.
    Cher SN; Chausm AB; Bellavia JV; Wallach S
    Endocrinology; 1970 Jun; 86(6):1337-46. PubMed ID: 5441870
    [No Abstract]   [Full Text] [Related]  

  • 36. Humoral hypercalcaemia of malignancy: metabolic and histomorphometric studies during surgical management of the primary tumour.
    Ralston SH; Boyce BF; Cowan RA; Gardner MD; Dryburgh FJ; Boyle IT
    Q J Med; 1986 Mar; 58(227):325-35. PubMed ID: 3016790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Calcitonin and calcium content of the blood of patients with thyroid pathology].
    Gapanovich NS; Romanchak MN; Mokhort TV; Livshits IB
    Probl Endokrinol (Mosk); 1983; 29(1):30-4. PubMed ID: 6835953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporotic cytokines and bone metabolism on rats with induced hyperthyroidism; changes as a result of reversal to euthyroidism.
    Simsek G; Karter Y; Aydin S; Uzun H
    Chin J Physiol; 2003 Dec; 46(4):181-6. PubMed ID: 15074839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of calcitonin on bone resorption in hyperthyroidism: a placebo-controlled clinical study.
    Akçay MN; Akçay G; BIlen H
    J Bone Miner Metab; 2004; 22(2):90-3. PubMed ID: 14999518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.